Central Retinal Vein Occlusion

Shares of Regeneron Pharmaceuticals (NASDAQ: REGN) were trading at new all-time high levels on Wednesday afternoon on concerns that rival Allergan (NYSE: AGN) may have problems moving its unnamed vision-loss drug into late-stage trials. The speculation is that Allergan believes it may have...